


Healthcare Industry News: H. Lundbeck A/S
News Release - October 24, 2011
FDA Approves ONFI(TM) (clobazam) for the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Patients Two Years and Older
Source: Lundbeck
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
